Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
ORIC-533 / ORIC Pharma
ORIC-533-01, NCT05227144: Study of ORIC-533 in Relapsed or Refractory Multiple Myeloma	Recruiting	1b	56	Canada, US	ORIC-533	ORIC Pharmaceuticals	Relapsed or Refractory Multiple Myeloma	06/24	06/24